EV Biologics Inc - YECO stock
OTC Symbol: YECO
About
EV Biologics, Inc. is a biotechnology company based in Cheyenne, Wyoming, focused on the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It utilizes its proprietary multifunctional EV platform to develop vaccines, therapeutics, and cures, and also explores human mesenchymal and other stem cell-derived products for the cosmetic and biopharmaceutical markets. The company was previously known as Yulong Eco-Materials Limited before changing its name to EV Biologics, Inc. in August 2020 and was incorporated in 2011.[1]
History
EV Biologics, Inc. was incorporated in 2011 and is headquartered in Cheyenne, Wyoming. The company is a biotechnology firm focused on the commercial development of extracellular vesicles (EVs) for diagnostics and therapeutics. EVs are small vesicles released by cells that play important roles in cell communication and are being explored for their potential use in various biomedical applications, including diagnostics and drug delivery.[2]
The company's prior name was Yulong Eco-Materials Limited before undergoing a name change to EV Biologics, Inc. in August 2020. The reason for the name change was not provided in the available information.[3]
- ↑ Yahoo Finance. YECO Stock Profile. Retrieved on 8/29/2023.
- ↑ Stock Analysis. EV Biologics, Inc. Retrieved on 8/20/2023.
- ↑ Accesswire. Yulong Changes Name to EV Biologics. August 6, 2020.
